Relation between dysfunction of nitric oxide synthase and angiogenesis

一氧化氮合酶功能障碍与血管生成的关系

基本信息

  • 批准号:
    09672334
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Reactive oxygen species (ROS) have been known to induce tissue injury in ischemialreperfusion and inflammation. Recently, however, it has beenTeported that-ROS regulates cel-lular-function such as proliferation. Interestingly, nitric oxide synthase (NOS) from brain releases ROS instead of nitric oxide (NO) when tetrahydrobiopterin (BH4), a cofactor of NOS, is decreased. The purpose of this study was to determine whether endothelial isoform of NOS also produces ROS with decreasing BH4, and the dysfunction of NOS affects angiogenesis. Addition of calcium ionophore to endothelial cells (ECs) released 0_2 which was measured by using MCLA, a Cypridina luciferin analogue. The calcium ionophore-induced 0_2 release was further stimulated by the treatment with 2,4-diamino-6-hydroxyprimidine (DAHP), an inhibitor of BH4 synthesis. Moreover, he calcium ionophore-induced O_2 release in the DAHP treated cells was strongly inhibited by NOS inhibitor. These findings suggest that endothelial isoform of NOS also produces ROS with decreasing BH4 content. We next examined the effect of H_20_2, one of the ROS, on in vitro angiogenesis. The low concentrations of H_20 stimulated angiogenesis. Ets-1 is a member of the ets gene family of transcription factors, which regulates the expression of urokinase plasminogen activator and matrix metalloprotease-1. Interestingly, H_20_2, increased the ets-l mRNA in ECs. The H_2_2-stimulated angiogenesis was completely blocked by an ets-1 antisense oligonucleotide. These results indicate that low concentrations of H_2O_2 stimulate angiogenesis, and the H_20_2-induced angiogenesis is likely to be mediated by the transcription factor ets-l. In the present study, we were not able to determine whether ROS from NOS affect angiogenesis, since DAHP itself has an inhibiting effect of angiogenesis. Future studies will be needed to find more selective inhibitor for BH4 synthesis.
活性氧(Reactive oxygen species,ROS)在缺血再灌注损伤和炎症反应中起重要作用.然而,最近的研究表明,-ROS调节细胞的功能,如增殖。有趣的是,当NOS的辅因子四氢生物蝶呤(BH 4)减少时,脑中的一氧化氮合酶(NOS)释放ROS而不是一氧化氮(NO)。本研究的目的是确定是否内皮型NOS也产生ROS与减少BH 4,NOS功能障碍影响血管生成。加入钙离子载体的内皮细胞(ECs)释放O_2,这是通过使用MCLA,Cypridina alcohol in类似物测量。BH_4合成抑制剂2,4-二氨基-6-羟基嘧啶(DAHP)可进一步促进钙离子载体诱导的O_2释放。NOS抑制剂可明显抑制DAHP诱导的细胞O_2释放。这些发现表明,内皮型NOS也产生ROS与减少BH 4含量。我们接下来检查了H_2O_2(ROS之一)对体外血管生成的影响。低浓度H_20刺激血管生成。Ets-1是ets基因转录因子家族的成员,调节尿激酶纤溶酶原激活物和基质金属蛋白酶-1的表达。有趣的是,H_2O_2增加了EC中ets-lmRNA的表达。ets-1反义寡核苷酸可完全阻断H_2_2诱导的血管生成。这些结果表明,低浓度H_2O_2刺激血管生成,H_2O_2诱导的血管生成可能是由转录因子ets-1介导的。在本研究中,我们不能确定来自NOS的ROS是否影响血管生成,因为DAHP本身具有抑制血管生成的作用。未来的研究将需要找到更有选择性的BH 4合成抑制剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SHINJI NAITO: "Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells" Am.J.Physiol. 247. C472-C480 (1998)
Shinji NAITO:“Ets-1 是血管平滑肌细胞中由 ET-1 和 PDGF-BB 激活的早期反应基因”Am.J.Physiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
MASAKO YASUDA: "STIMULATION OF IN VITRO ANGIOGENESIS BY HYDROGEN PEROXIDE AND THE RELATION WITH ETS-1 IN ENDOTHELIAL CELLS" Life Sciences. 64. 249-258 (1999)
Masako Yasuda:“过氧化氢刺激体外血管生成及其与内皮细胞中 ETS-1 的关系”生命科学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masakazu Ishii: "Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin content." Life Sciences. 61・7. 739-747 (1997)
Masakazu Ishii:“一氧化氮合酶功能障碍加速氧化应激诱导的内皮细胞死亡,并伴随四氢生物蝶呤含量的减少。” 61·7 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
SHUNICHI SHIMIZU: "Role of tetrahydrobiopterin in the function of nitric oxide synthase and its cytoprotective effect(Review)" INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2. 533-540 (1998)
清水俊一:“四氢生物蝶呤在一氧化氮合酶功能中的作用及其细胞保护作用(综述)”国际分子医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
SHUNICHI SHIMIZU: "Role of tetrahydrobiopterin in the function of nitric oxide synthase and its cytoprotective effect (Review)" INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2. 533-540 (1998)
Shunichi Shimizu:“四氢生物蝶呤在一氧化氮合酶功能及其细胞保护作用中的作用(综述)”国际分子医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MOMOSE Kazutaka其他文献

MOMOSE Kazutaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MOMOSE Kazutaka', 18)}}的其他基金

THE INVESTIGATION OF THE THERAPEUTIC MECHANISMS OF ANTIDEPRESSANT ON NEUROTRANSMITTER RELEASE
抗抑郁药对神经递质释放的治疗机制研究
  • 批准号:
    13670097
  • 财政年份:
    2001
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Variation of nitric oxide synthase activity in encothelial cells and effects of the variation on the cell injury
内皮细胞一氧化氮合酶活性的变化及其对细胞损伤的影响
  • 批准号:
    07672474
  • 财政年份:
    1995
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of Muscarinic Receptors in Singl Smooth Muscle Cells
单个平滑肌细胞中毒蕈碱受体的表征
  • 批准号:
    01571224
  • 财政年份:
    1989
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Radical Intermediates of Nitric Oxide Synthase & Myocardial Ischemia Reperfusion
一氧化氮合酶自由基中间体
  • 批准号:
    8220816
  • 财政年份:
    2010
  • 资助金额:
    $ 1.54万
  • 项目类别:
Radical Intermediates of Nitric Oxide Synthase & Myocardial Ischemia Reperfusion
一氧化氮合酶自由基中间体
  • 批准号:
    8018542
  • 财政年份:
    2010
  • 资助金额:
    $ 1.54万
  • 项目类别:
Radical Intermediates of Nitric Oxide Synthase & Myocardial Ischemia Reperfusion
一氧化氮合酶自由基中间体
  • 批准号:
    7783873
  • 财政年份:
    2010
  • 资助金额:
    $ 1.54万
  • 项目类别:
Radical Intermediates of Nitric Oxide Synthase & Myocardial Ischemia Reperfusion
一氧化氮合酶自由基中间体
  • 批准号:
    8447346
  • 财政年份:
    2010
  • 资助金额:
    $ 1.54万
  • 项目类别:
Modulators of Nitric Oxide Synthase Activity in Sickle Cell Disease
镰状细胞病中一氧化氮合酶活性的调节剂
  • 批准号:
    7654865
  • 财政年份:
    2009
  • 资助金额:
    $ 1.54万
  • 项目类别:
Modulators of Nitric Oxide Synthase Activity in Sickle Cell Disease
镰状细胞病中一氧化氮合酶活性的调节剂
  • 批准号:
    7918872
  • 财政年份:
    2009
  • 资助金额:
    $ 1.54万
  • 项目类别:
Hypothermia for Cardiac Arrest: Optimizing Akt-Nitric Oxide Synthase Signaling
低温治疗心脏骤停:优化 Akt-一氧化氮合酶信号转导
  • 批准号:
    8294612
  • 财政年份:
    2008
  • 资助金额:
    $ 1.54万
  • 项目类别:
Hypothermia for Cardiac Arrest: Optimizing Akt-Nitric Oxide Synthase Signaling
低温治疗心脏骤停:优化 Akt-一氧化氮合酶信号转导
  • 批准号:
    7862489
  • 财政年份:
    2008
  • 资助金额:
    $ 1.54万
  • 项目类别:
Hypothermia for Cardiac Arrest: Optimizing Akt-Nitric Oxide Synthase Signaling
低温治疗心脏骤停:优化 Akt-一氧化氮合酶信号转导
  • 批准号:
    8098021
  • 财政年份:
    2008
  • 资助金额:
    $ 1.54万
  • 项目类别:
Hypothermia for Cardiac Arrest: Optimizing Akt-Nitric Oxide Synthase Signaling
低温治疗心脏骤停:优化 Akt-一氧化氮合酶信号转导
  • 批准号:
    7676749
  • 财政年份:
    2008
  • 资助金额:
    $ 1.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了